Aeglea BioTherapeutics - 48 Year Dividend History | AGLE

Historical dividend payout and yield for Aeglea BioTherapeutics (AGLE) since 1971. The current TTM dividend payout for Aeglea BioTherapeutics (AGLE) as of April 24, 2019 is $0.00. The current dividend yield for Aeglea BioTherapeutics as of April 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.214B $0.004B
Aeglea BioTherapeutics, Inc. is a biotechnology company which is engaged in developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer. Its portfolio of products consists of AEB1102, AEB3103, AEB2109 and AEB4104 which are in different clinical trial phase. Aeglea BioTherapeutics, Inc. is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.723B 12.48
Gilead Sciences (GILD) United States $80.369B 10.23
Bio-Techne Corp (TECH) United States $7.248B 48.83